Ysios news
04.12.19
Anaconda biomed secures €20 million round of funding
16.07.19
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
portfolio news
31.03.20
AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI
24.02.20
Aura Biosciences Presents Updated Phase 1b/2 Clinical Data for AU-011 at the 43rd Annual Macula Society Meeting
